FAP and breast carcinoma: Additionally, the CAF-S1 FAP+ subpopulation is an important source of CXCL12 secretion, which plays a crucial role in resistance to anti-PD-1 and anti-CTLA-4 immunotherapies in pancreatic, ovarian, and breast cancer [27,28].